Related Experiment Video
Updated: Jan 11, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
Published on: July 18, 2025
Sedentary Behavior as a Risk Factor for Liver Fibrosis Development in Patients with Metabolic Dysfunction-Associated
Antonella Bianco1, Caterina Bonfiglio2, Isabella Franco1
1Laboratory of Movement and Wellness, National Institute of Gastroenterology IRCCS "Saverio de Bellis", Castellana Grotte, 70013 Bari, Italy.
Objective measurement of daily energy expenditure shows sedentary behavior is linked to increased liver stiffness in adults with metabolic dysfunction-associated fatty liver disease (MASLD). Reducing sedentary time may help slow fibrosis progression.
Area of Science:
- Hepatology
- Metabolic Diseases
- Public Health
Background:
- Metabolic dysfunction-associated fatty liver disease (MASLD) impacts 20% of Italians, costing the NHS €7.94 billion annually.
- Advanced liver fibrosis is a key predictor of adverse outcomes in MASLD patients.
- Sedentary behavior (SB) is a modifiable risk factor, but evidence often relies on self-reported data.
Purpose of the Study:
- To investigate the association between objectively measured daily energy expenditure and liver stiffness in adults with MASLD.
- To determine if sedentary behavior correlates with increased liver stiffness in this population.
Main Methods:
- Cross-sectional analysis of 104 adults (18-65 years) with obesity and moderate-to-severe steatosis.
- Objective assessment of daily energy expenditure using 7-day wrist-worn actigraphy (METs/day).
- Non-invasive measurement of liver stiffness (LSM, kPa) via transient elastography (FibroScan®).
Main Results:
- Lower daily energy expenditure was independently associated with higher liver stiffness (p=0.002).
- Each 1-MET increase correlated with a -1.239 kPa reduction in liver stiffness.
- Sedentary individuals (≤1.5 METs) showed significantly higher liver stiffness (p=0.03) compared to non-sedentary individuals.
Conclusions:
- Objectively measured sedentary behavior is independently linked to increased liver stiffness in MASLD patients with obesity.
- Reducing sedentary time may be a practical strategy to mitigate liver fibrosis progression.
- Further longitudinal studies are needed to confirm causality and evaluate interventions in broader MASLD populations.
More Related Videos
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...